netFormulary NHS
North East and North Cumbria
ICS Formulary
 Search
 Results

Looking for Dapagliflozin found 10 matches

Open monograph to display formulary status BNF Category
  Dapagliflozin  (Forxiga®) Endocrine system - SGL2 inhibitors - 06.01.02.03
  Dapafliflozin  (Forxiga®) Cardiovascular system - SGLT-2 inhibitor - 02.15
 


Linkslink in drug section Link to Drug Section link in subsection Link to document
link in drug section NICE TA288: Dapagliflozin in combination therapy for treating type 2 diabetes (06.01.02.03)
link in drug section NICE TA390: Canagliflozin, dapagliflozin and empagliflozin as monotherapies for treating type 2 diabetes (06.01.02.03)
link in drug section NICE TA390: Canagliflozin, dapagliflozin and empagliflozin as monotherapies for treating type 2 diabetes (06.01.02.03)
link in drug section NICE TA390: Canagliflozin, dapagliflozin and empagliflozin as monotherapies for treating type 2 diabetes (06.01.02.03)
link in drug section NICE TA418: Dapagliflozin in triple therapy for treating type 2 diabetes (06.01.02.03)
link in drug section NICE TA679: Dapagliflozin for treating chronic heart failure with reduced ejection fraction (02.15)
link in drug section NICE TA775: Dapagliflozin for treating chronic kidney disease (06.01.02.03)
link in drug section NICE TA902: Dapagliflozin for treating chronic heart failure with preserved or mildly reduced ejection fraction (02.15)


 

netFormulary